Cargando…

Treatment of Acute Lymphoblastic Leukemia from Traditional Chinese Medicine

Acute lymphoblastic leukemia (ALL) is a cancer that immature white blood cells continuously overproduce in the bone marrow. These cells crowd out normal cells in the bone marrow bringing damage and death. Methotrexate (MTX) is a drug used in the treatment of various cancer and autoimmune diseases. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsiao, Ya-Li, Chang, Pei-Chun, Huang, Hung-Jin, Kuo, Chia-Chen, Chen, Calvin Yu-Chian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055129/ https://www.ncbi.nlm.nih.gov/pubmed/25136372 http://dx.doi.org/10.1155/2014/601064

Ejemplares similares

In Silico Design of BACE1 Inhibitor for Alzheimer's Disease by Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

In Silico Investigation of Cytochrome P450 2C9 in relation to Aging Using Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Pharmacological Chaperone Design for Reducing Risk Factor of Parkinson's Disease from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Lead Discovery for Alzheimer's Disease Related Target Protein RbAp48 from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Computational Design of Apolipoprotein E4 Inhibitors for Alzheimer's Disease Therapy from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Two Birds with One Stone? Possible Dual-Targeting H1N1 Inhibitors from Traditional Chinese Medicine
por: Chang, Su-Sen, et al.
Publicado: (2011)

Finding Inhibitors of Mutant Superoxide Dismutase-1 for Amyotrophic Lateral Sclerosis Therapy from Traditional Chinese Medicine
por: Huang, Hung-Jin, et al.
Publicado: (2014)

Lead Screening for HIV of C-C Chemokine Receptor Type 5 Receptor Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Drug Design for Neuropathic Pain Regulation from Traditional Chinese Medicine
por: Tou, Weng Ieong, et al.
Publicado: (2013)

Lead Screening for Chronic Obstructive Pulmonary Disease of IKK2 Inhibited by Traditional Chinese Medicine
por: Tsou, Yung-An, et al.
Publicado: (2014)

Treatment of Rheumatoid Arthritis with Traditional Chinese Medicine
por: Lee, Wen-Yuan, et al.
Publicado: (2014)

TCM Database@Taiwan: The World's Largest Traditional Chinese Medicine Database for Drug Screening In Silico
por: Chen, Calvin Yu-Chian
Publicado: (2011)

In Silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors from Traditional Chinese Medicine
por: Chen, Kuan-Yu, et al.
Publicado: (2012)

Lead Screening for HIV-1 Integrase (IN) Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

In Silico Investigation of Potential Src Kinase Ligands from Traditional Chinese Medicine
por: Tou, Weng Ieong, et al.
Publicado: (2012)

When Modern Technology Meets Ancient Traditional Chinese Medicine
por: Chen, Calvin Yu-Chian, et al.
Publicado: (2015)

Investigation of Potent Lead for Acquired Immunodeficiency Syndrome from Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

An Investigation of Small GTPases in relation to Liver Tumorigenesis Using Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Lead Screening for CXCR4 of the Human HIV Infection Receptor Inhibited by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

The Inhibition of Folylpolyglutamate Synthetase (folC) in the Prevention of Drug Resistance in Mycobacterium tuberculosis by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Investigation of Estrogen Receptor (ESR1) for Breast Cancer from Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Potential Retinoid X Receptor Agonists for Treating Alzheimer's Disease from Traditional Chinese Medicine
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

Drug Design of Cyclin-Dependent Kinase 2 Inhibitor for Melanoma from Traditional Chinese Medicine
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Treatment of Cardiovascular Disease by Traditional Chinese Medicine against Pregnane X Receptor
por: Chen, Kuen-Bao, et al.
Publicado: (2014)

Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

Possible Inhibitor from Traditional Chinese Medicine for the β Form of Calcium-Dependent Protein Kinase Type II in the Treatment of Major Depressive Disorder
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Uroporphyrinogen Decarboxylase as a Potential Target for Specific Components of Traditional Chinese Medicine: A Virtual Screening and Molecular Dynamics Study
por: Tsou, Yung-An, et al.
Publicado: (2012)

Potential Protein Phosphatase 2A Agents from Traditional Chinese Medicine against Cancer
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

Potential Smoothened Inhibitor from Traditional Chinese Medicine against the Disease of Diabetes, Obesity, and Cancer
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

In Silico Investigation of Traditional Chinese Medicine Compounds to Inhibit Human Histone Deacetylase 2 for Patients with Alzheimer's Disease
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Insight into HIV of IFN-Induced Myxovirus Resistance 2 (MX2) Expressed by Traditional Chinese Medicine
por: Hung, Tzu-Chieh, et al.
Publicado: (2014)

Ligand-Based and Structure-Based Investigation for Alzheimer's Disease from Traditional Chinese Medicine
por: Liao, Kai Hsin, et al.
Publicado: (2014)

In Silico Design for Adenosine Monophosphate-Activated Protein Kinase Agonist from Traditional Chinese Medicine for Treatment of Metabolic Syndromes
por: Tang, Hsin-Chieh, et al.
Publicado: (2014)

In Silico Investigation of Traditional Chinese Medicine for Potential Lead Compounds as SPG7 Inhibitors against Coronary Artery Disease
por: Chen, Kuen-Bao, et al.
Publicado: (2016)

The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia
por: Pei, Jen-Sheng, et al.
Publicado: (2018)

In Silico Investigation of Potential TRAF6 Inhibitor from Traditional Chinese Medicine against Cancers
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

In Silico Investigation of Potential mTOR Inhibitors from Traditional Chinese Medicine for Treatment of Leigh Syndrome
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

In Silico Investigation of Potential Pyruvate Kinase M2 Regulators from Traditional Chinese Medicine against Cancers
por: Chen, Kuan-Chung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_dmvoi8710c8ffap56booe0dopa